Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2014 | 1 |
2015 | 1 |
2017 | 2 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Combining oncolytic virotherapy and cytotoxic therapies to fight cancer.
Curr Pharm Des. 2014;20(42):6513-21. doi: 10.2174/1381612820666140826152420.
Curr Pharm Des. 2014.
PMID: 25341928
Review.
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.
Garcia-Carbonero R, Bazan-Peregrino M, Gil-Martín M, Álvarez R, Macarulla T, Riesco-Martinez MC, Verdaguer H, Guillén-Ponce C, Farrera-Sal M, Moreno R, Mato-Berciano A, Maliandi MV, Torres-Manjon S, Costa M, Del Pozo N, Martínez de Villarreal J, Real FX, Vidal N, Capella G, Alemany R, Blasi E, Blasco C, Cascalló M, Salazar R.
Garcia-Carbonero R, et al. Among authors: maliandi mv.
J Immunother Cancer. 2022 Mar;10(3):e003255. doi: 10.1136/jitc-2021-003255.
J Immunother Cancer. 2022.
PMID: 35338084
Free PMC article.
Item in Clipboard
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation.
Farrera-Sal M, Moreno R, Mato-Berciano A, Maliandi MV, Bazan-Peregrino M, Alemany R.
Farrera-Sal M, et al. Among authors: maliandi mv.
Mol Ther Oncolytics. 2021 May 29;22:27-35. doi: 10.1016/j.omto.2021.05.009. eCollection 2021 Sep 24.
Mol Ther Oncolytics. 2021.
PMID: 34377767
Free PMC article.
Item in Clipboard
National funding for mental health research in Finland, France, Spain and the United Kingdom.
Hazo JB, Gandré C, Leboyer M, Obradors-Tarragó C, Belli S, McDaid D, Park AL, Maliandi MV, Wahlbeck K, Wykes T, van Os J, Haro JM, Chevreul K; ROAMER consortium.
Hazo JB, et al. Among authors: maliandi mv.
Eur Neuropsychopharmacol. 2017 Sep;27(9):892-899. doi: 10.1016/j.euroneuro.2017.06.008. Epub 2017 Jun 21.
Eur Neuropsychopharmacol. 2017.
PMID: 28647453
Item in Clipboard
Pancreatic cancer gene therapy: from molecular targets to delivery systems.
Fillat C, Jose A, Bofill-Deros X, Mato-Berciano A, Maliandi MV, Sobrevals L.
Fillat C, et al. Among authors: maliandi mv.
Cancers (Basel). 2011 Jan 18;3(1):368-95. doi: 10.3390/cancers3010368.
Cancers (Basel). 2011.
PMID: 24212620
Free PMC article.
Item in Clipboard
AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation.
Maliandi MV, Mato-Berciano A, Sobrevals L, Roué G, José A, Fillat C.
Maliandi MV, et al.
Mol Cancer. 2015 Jul 31;14:146. doi: 10.1186/s12943-015-0413-2.
Mol Cancer. 2015.
PMID: 26227809
Free PMC article.
Item in Clipboard
A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel.
Mato-Berciano A, Raimondi G, Maliandi MV, Alemany R, Montoliu L, Fillat C.
Mato-Berciano A, et al. Among authors: maliandi mv.
Oncotarget. 2017 Apr 4;8(14):22700-22715. doi: 10.18632/oncotarget.15169.
Oncotarget. 2017.
PMID: 28186974
Free PMC article.
Item in Clipboard
Cite
Cite